P Pozzilli-Paolo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Corrigendum to 'What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?' [JDC, Vol. 39, Issue 10, October 2025, 109132].
Journal: Journal of diabetes and its complications
Published: December 04, 2025
Corrigendum to "Divergence in prediabetes guidelines - A global perspective" [Diabetes Res. Clin. Pract. 223 (2025) 112142].
Journal: Diabetes research and clinical practice
Published: July 16, 2025
Neglected GLP-1 receptors in the eyes and nose: possible correlation with regulation of appetite.
Journal: Endocrine
Published: June 18, 2025
The body mass index of females in impressionist paintings: a contrast with modern ideals.
Journal: International journal of obesity (2005)
Published: June 17, 2025
What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?
Journal: Journal of diabetes and its complications
Published: May 07, 2025
Divergence in prediabetes guidelines - A global perspective.
Journal: Diabetes research and clinical practice
Published: February 03, 2025
Beyond the insulin pump: Unraveling diabetes tech dependency.
Journal: Diabetes research and clinical practice
Published: July 08, 2024
The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.
Journal: Diabetes research and clinical practice
Published: October 25, 2021
Cosimo I de Medici and his Merseburg triad of Graves' disease.
Journal: Journal of endocrinological investigation
Published: June 01, 2021
Medical congresses at the click of a mouse.
Journal: Diabetes research and clinical practice
Published: April 09, 2021
The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study.
Journal: Acta diabetologica
Published: September 09, 2020
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths.
Journal: Diabetes research and clinical practice
Published: July 24, 2020
Last Updated: 09/26/2026